Disc Medicine (IRON) Short term Debt (2020 - 2022)

Disc Medicine (IRON) has 3 years of Short term Debt data on file, last reported at $2.9 million in Q2 2022.

• Quarterly Short term Debt fell 41.74% year-over-year to $2.9 million in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $2.9 million (down 41.74% YoY) and the FY2021 annual result came in at $6.4 million, up 29.0% from the prior year.
• Short term Debt slipped to $2.9 million in Q2 2022 per IRON's latest filing, from $4.2 million in the prior quarter.
• Across five years, Short term Debt topped out at $6.4 million in Q4 2021 and bottomed at $2.9 million in Q2 2022.
• The 3-year median for Short term Debt is $5.0 million (2020), against an average of $4.8 million.
• The widest annual swing landed in 2021, when Short term Debt advanced 29.0%; it then plunged 41.74% in 2022.
• Tracing IRON's Short term Debt over 3 years: stood at $5.0 million in 2020, then gained by 29.0% to $6.4 million in 2021, then tumbled by 54.84% to $2.9 million in 2022.
• Per Business Quant, the three latest IRON Short term Debt figures stand at $2.9 million (Q2 2022), $4.2 million (Q1 2022), and $6.4 million (Q4 2021).

Peer Comparison